715 related articles for article (PubMed ID: 25238885)
21. Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.
Veselka J; Faber L; Liebregts M; Cooper R; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg J; Stables RH; Jensen MK
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512112
[TBL] [Abstract][Full Text] [Related]
22. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.
Steggerda RC; Damman K; Balt JC; Liebregts M; ten Berg JM; van den Berg MP
JACC Cardiovasc Interv; 2014 Nov; 7(11):1227-34. PubMed ID: 25326737
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.
Liebregts M; Faber L; Jensen MK; Vriesendorp PA; Januska J; Krejci J; Hansen PR; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg JM; Veselka J
JACC Cardiovasc Interv; 2017 Jun; 10(11):1134-1143. PubMed ID: 28595881
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: technical review and long-term clinical and echocardiographic outcomes.
Leal S; Galeote G; Jiménez-Valero S; Sánchez-Recalde A; Salinas P; Ruiz AS; Orbe LC; Dominguéz F; Moreno R; López-Sendón JL
Rev Port Cardiol; 2012 May; 31(5):363-71. PubMed ID: 22482474
[TBL] [Abstract][Full Text] [Related]
25. Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy.
Cavigli L; Fumagalli C; Maurizi N; Rossi A; Arretini A; Targetti M; Passantino S; Girolami F; Tomberli B; Baldini K; Tomberli A; Antoniucci D; Yacoub MH; Marchionni N; Stefano PL; Cecchi F; Olivotto I
Int J Cardiol; 2018 Dec; 273():155-161. PubMed ID: 30213605
[TBL] [Abstract][Full Text] [Related]
26. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
[TBL] [Abstract][Full Text] [Related]
27. Routine Papillary Muscle Realignment and Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.
Song HK; Turner J; Macfie R; Kumar S; Mannello MJ; Smith D; Bhamidipati C; Raman J; Tibayan F; Heitner SB
Ann Thorac Surg; 2018 Sep; 106(3):670-675. PubMed ID: 29753818
[TBL] [Abstract][Full Text] [Related]
28. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
Moravsky G; Bruchal-Garbicz B; Jamorski M; Ralph-Edwards A; Gruner C; Williams L; Woo A; Yang H; Laczay B; Rakowski H; Carasso S
J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
[TBL] [Abstract][Full Text] [Related]
29. Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
Cui H; Schaff HV; Wang S; Lahr BD; Rowin EJ; Rastegar H; Hu S; Eleid MF; Dearani JA; Kimmelstiel C; Maron BJ; Nishimura RA; Ommen SR; Maron MS
J Am Coll Cardiol; 2022 May; 79(17):1647-1655. PubMed ID: 35483751
[TBL] [Abstract][Full Text] [Related]
30. What is the best surgical treatment for obstructive hypertrophic cardiomyopathy and degenerative mitral regurgitation?
Wan CK; Dearani JA; Sundt TM; Ommen SR; Schaff HV
Ann Thorac Surg; 2009 Sep; 88(3):727-31; discussion 731-2. PubMed ID: 19699887
[TBL] [Abstract][Full Text] [Related]
31. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
Zhu C; Tang B; Cui H; Wang S; Xiao M; Chen Z; Meng Y; Zhao S; Song Y; Yu Q; Wang S
J Card Surg; 2019 Jul; 34(7):533-540. PubMed ID: 31111576
[TBL] [Abstract][Full Text] [Related]
32. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
[TBL] [Abstract][Full Text] [Related]
33. Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.
Veselka J; Jensen MK; Liebregts M; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Tomasov P; Adlova R; Bundgaard H; Steggerda R; Ten Berg J; Faber L
Eur Heart J; 2016 May; 37(19):1517-23. PubMed ID: 26746632
[TBL] [Abstract][Full Text] [Related]
34. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy.
Menon SC; Ackerman MJ; Ommen SR; Cabalka AK; Hagler DJ; O'Leary PW; Dearani JA; Cetta F; Eidem BW
J Am Soc Echocardiogr; 2008 Jun; 21(6):684-8. PubMed ID: 18187287
[TBL] [Abstract][Full Text] [Related]
35. Myectomy versus alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Afanasyev AV; Bogachev-Prokophiev AV; Kashtanov MG; Astapov DA; Zalesov AS; Budagaev SA; Sharifulin RM; Idov EM; Zheleznev SI
Interact Cardiovasc Thorac Surg; 2020 Aug; 31(2):158-165. PubMed ID: 32386304
[TBL] [Abstract][Full Text] [Related]
36. Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.
Kimmelstiel C; Zisa DC; Kuttab JS; Wells S; Udelson JE; Wessler BS; Rastegar H; Kapur NK; Weintraub AR; Maron BJ; Maron MS; Rowin EJ
Circ Cardiovasc Interv; 2019 Jul; 12(7):e007673. PubMed ID: 31296080
[TBL] [Abstract][Full Text] [Related]
37. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score.
Ralph-Edwards A; Woo A; McCrindle BW; Shapero JL; Schwartz L; Rakowski H; Wigle ED; Williams WG
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):351-8. PubMed ID: 15678046
[TBL] [Abstract][Full Text] [Related]
38. Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis.
Yokoyama Y; Shimoda T; Shimada YJ; Shimamura J; Akita K; Yasuda R; Takayama H; Kuno T
Eur J Cardiothorac Surg; 2023 Mar; 63(3):. PubMed ID: 36782361
[TBL] [Abstract][Full Text] [Related]
39. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Safe and Apparently Efficacious But Does Reporting of Aggregate Outcomes Hide Less-Favorable Results, Experienced by a Substantial Proportion of Patients?
Cooper RM; Shahzad A; McShane J; Stables RH
J Invasive Cardiol; 2015 Jul; 27(7):301-8. PubMed ID: 26136275
[TBL] [Abstract][Full Text] [Related]
40. Effects of septal myectomy on left ventricular diastolic function and left atrial volume in patients with hypertrophic cardiomyopathy.
Tower-Rader A; Furiasse N; Puthumana JJ; Kruse J; Li Z; Andrei AC; Rigolin V; Bonow RO; McCarthy PM; Choudhury L
Am J Cardiol; 2014 Nov; 114(10):1568-72. PubMed ID: 25260948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
